RTRX Biotech Retrophin

About RTRX

Travere Therapeutics, Inc. is a biopharmaceutical company. It engages in the identification, development, commercialization, and distribution of therapies to people living with rare diseases. The firm's products include Chenodal, Cholbam, and Thiola. The company was founded by Martin Shkreli on February 7, 2008 and is headquartered in San Diego, CA.
50

Neutral Sentiment

How do you feel about RTRX?

Advertisement|Remove ads.